CEO Ian Bothwell Increases Stake in Zeo Scientifix, Inc. via Equity Grants

Ian T. Bothwell, the Chief Executive Officer and Chief Financial Officer of Zeo Scientifix, Inc. (ZEOX), filed Amendment No. 3 to his Schedule 13D on May 15, 2026. This filing reports an increase in beneficial ownership to 1,195,094 shares of common stock, representing 14.7% of the class. The increase resulted from the grant of 55,000 stock options on May 8, 2025, and 175,000 restricted shares on January 14, 2026, issued under the company's 2021 Equity Incentive Plan. The reported beneficial ownership includes 87,500 restricted shares vesting in July 2026, 187,500 shares issuable upon warrant exercise, and 180,000 shares issuable upon option exercise. Additionally, Bothwell holds 50 shares of Series C Preferred Stock, which grants him an additional 25.5% of the total voting power, bringing his aggregate voting control to 40.2%. The reporting person has sole voting and dispositive power over the common shares and currently has no plans for extraordinary corporate transactions or material changes to the issuer's structure.